A new trading day began on Friday, with GeneDx Holdings Corp (NASDAQ: WGS) stock price up 9.09% from the previous day of trading, before settling in for the closing price of $55.00. WGS’s price has ranged from $1.16 to $57.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.08%. Meanwhile, its annual earnings per share averaged 76.59%. With a float of $19.13 million, this company’s outstanding shares have now reached $25.98 million.
Let’s determine the extent of company efficiency that accounts for 1000 employees. In terms of profitability, gross margin is 50.22%, operating margin of -36.84%, and the pretax margin is -48.56%.
GeneDx Holdings Corp (WGS) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of GeneDx Holdings Corp is 28.96%, while institutional ownership is 58.65%. The most recent insider transaction that took place on Sep 17 ’24, was worth 547,956. Before that another transaction happened on Sep 16 ’24, when Company’s Chief Executive Officer sold 10,501 for $37.59, making the entire transaction worth $394,733. This insider now owns 103,706 shares in total.
GeneDx Holdings Corp (WGS) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -0.82 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 76.59% per share during the next fiscal year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Here are GeneDx Holdings Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.22. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.50, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of GeneDx Holdings Corp (WGS)
Looking closely at GeneDx Holdings Corp (NASDAQ: WGS), its last 5-days average volume was 0.76 million, which is a jump from its year-to-date volume of 0.42 million. As of the previous 9 days, the stock’s Stochastic %D was 88.61%. Additionally, its Average True Range was 3.21.
During the past 100 days, GeneDx Holdings Corp’s (WGS) raw stochastic average was set at 98.08%, which indicates a significant increase from 96.79% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.70% in the past 14 days, which was lower than the 74.25% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.91, while its 200-day Moving Average is $20.96. However, in the short run, GeneDx Holdings Corp’s stock first resistance to watch stands at $62.47. Second resistance stands at $64.93. The third major resistance level sits at $69.06. If the price goes on to break the first support level at $55.87, it is likely to go to the next support level at $51.74. Now, if the price goes above the second support level, the third support stands at $49.27.
GeneDx Holdings Corp (NASDAQ: WGS) Key Stats
With a market capitalization of 1.62 billion, the company has a total of 26,122K Shares Outstanding. Currently, annual sales are 202,570 K while annual income is -175,770 K. The company’s previous quarter sales were 70,510 K while its latest quarter income was -29,170 K.
